Enhanced delivery of ganciclovir to the brain through the use of redox targeting
Open Access
- 1 April 1994
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 38 (4) , 817-823
- https://doi.org/10.1128/aac.38.4.817
Abstract
Enhanced delivery of ganciclovir to the brain was demonstrated by a redox-based chemical delivery system. A ganciclovir monoester in which a 1-methyl-1,4-dihydronicotinate was covalently attached to one of the hydroxymethyl functions was prepared. The stability of the ganciclovir chemical delivery system (DHPG-CDS) was evaluated in aqueous buffers and organ homogenates. In vivo distribution studies in the rat indicated that while ganciclovir poorly penetrated into the central nervous system and was rapidly eliminated, DHPG-CDS provided for therapeutically relevant (2.7 microM) and sustained levels of the parent compound through 6 h. An analysis of the area under the concentration curve indicated that the chemical delivery system delivered five times more ganciclovir than that of the parent drug. The high levels in the brain and reduced levels in the blood gave a brain-to-blood drug concentration ratio of 2.54 for ganciclovir when delivered by the chemical delivery system, compared to a ratio of 0.063 when the parent drug was administered. These data suggest that DHPG-CDS could be a useful adjunct for the treatment of cytomegalovirus encephalitis.Keywords
This publication has 32 references indexed in Scilit:
- Brain, Blood, and Cerebrospinal Fluid Distribution of a Zidovudine Chemical Delivery System in RabbitsJournal of Pharmaceutical Sciences, 1991
- Antiviral activity and pharmacokinetics of HOE 602, an acyclic nucleoside, in animal modelsAntiviral Research, 1990
- GanciclovirDrugs, 1990
- Clinical Aspects of Cytomegalovirus RetinitisClinical Infectious Diseases, 1988
- Optimizing drug delivery to brain tumorsCancer Treatment Reviews, 1987
- The AIDS dementia complex: II. NeuropathologyAnnals of Neurology, 1986
- Pulmonary Complications of the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1984
- Neurological complications of acquired immune deficiency syndrome: Analysis of 50 patientsAnnals of Neurology, 1983
- Latent Infection and the Elusive CytomegalovirusClinical Infectious Diseases, 1983
- Activation by thymidine kinase and potent antiherpetic activity of 2′-nor-2′-deoxyguanosine (2′NDG)Biochemical and Biophysical Research Communications, 1982